Chembio Diagnostics develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV and syphilis antibodies. The Company's products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV 1/2 Assay Test, a DPP HIV-Syphilis multiplex test, and a test for the detection of Hepatitis-C. Chembio Diagnostics sells its products under a number of brands and labels. The Company has collaboration agreements to develop POC diagnostic tests for traumatic brain injury, a specific type of cancer and an undisclosed biomarker.

Type
Public
HQ
Medford, US
Founded
1985
Size (employees)
131 (est)
Chembio was founded in 1985 and is headquartered in Medford, US
Report incorrect company information

Key People/Management at Chembio

John Sperzel

John Sperzel

President and Chief Executive Officer

Chembio Office Locations

Chembio has an office in Medford
Medford, US (HQ)
3661 Horseblock Road
Show all (1)
Report incorrect company information

Chembio Financials and Metrics

Chembio Revenue

Embed Graph
Chembio's revenue was reported to be $24.02 m in FY, 2017
USD

Revenue (Q1, 2018)

7.7 m

Gross profit (Q1, 2018)

3.6 m

Gross profit margin (Q1, 2018), %

46.6%

Net income (Q1, 2018)

(652.3 k)

EBIT (Q1, 2018)

(654.3 k)

Market capitalization (18-Jul-2018)

157.9 m

Closing share price (18-Jul-2018)

11.2

Cash (31-Mar-2018)

12.5 m

EV

145.6 m
Chembio's current market capitalization is $157.9 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

29.5 m27.6 m24.3 m17.9 m24 m

Revenue growth, %

(6%)(12%)(26%)

Cost of goods sold

17.2 m16.8 m13.8 m9.4 m12.9 m

Gross profit

12.3 m10.8 m10.5 m8.5 m11.1 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

9.6 m5.8 m7.4 m7.3 m6.2 m6.7 m6.9 m6.6 m3.3 m3.7 m6.3 m4.1 m7.7 m

Cost of goods sold

5.6 m3.5 m4.4 m4.7 m3.5 m3.7 m4 m3.4 m1.7 m1.8 m3.2 m2.2 m4.1 m

Gross profit

4.1 m2.3 m3 m2.7 m2.7 m3 m2.9 m3.2 m1.6 m2 m3.1 m1.9 m3.6 m

Gross profit Margin, %

42%39%40%36%43%45%42%48%48%52%49%46%47%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

9.7 m4.6 m5.4 m10.6 m3.8 m

Accounts Receivable

525.6 m

Inventories

3.2 m3.6 m3.6 m3.3 m4.4 m

Current Assets

18.5 m17.7 m12.6 m18.1 m10.9 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

8 m9.1 m6.8 m3.7 m2.8 m1.6 m1.1 m2.7 m1.4 m12.2 m5.6 m3.7 m12.5 m

Inventories

3.7 m3.6 m4.1 m4 m3.7 m3.8 m3 m3.4 m3.5 m3.4 m3.8 m5 m5.8 m

Current Assets

18 m17.2 m17.5 m17 m16.2 m15.7 m15.2 m12 m10.4 m20.6 m15.9 m14.1 m22.9 m

PP&E

1.8 m1.9 m2.1 m2.1 m3 m2.8 m2.6 m2.2 m2 m1.8 m1.9 m2.1 m1.9 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

530.8 k(1.1 m)(2.4 m)(13.3 m)(6.4 m)

Depreciation and Amortization

607.8 k739.3 k1.4 m1.1 m1.3 m

Inventories

(700.7 k)(449.6 k)60.3 k242.8 k(1.1 m)

Accounts Payable

182.5 k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

716.7 k(224.7 k)(146 k)(270.6 k)(303.6 k)(8.3 m)(2.1 m)(1.6 m)(652.3 k)

Depreciation and Amortization

223 k

Inventories

4.1 m4 m3.7 m3.8 m3 m3.4 m3.5 m3.4 m3.8 m(1.4 m)

Accounts Payable

1.3 m
USDY, 2018

EV/EBIT

-222.5 x

EV/CFO

-62.8 x

Financial Leverage

1.2 x
Show all financial metrics

Chembio Operating Metrics

FY, 2016

Patents (US)

4

Products

3
Show all operating metrics

Chembio Revenue Breakdown

Embed Graph

Chembio revenue breakdown by geographic segment: 35.6% from South America, 37.2% from North America, 8.3% from Europe, 17.3% from Africa and 1.7% from Other

Report incorrect company information

Chembio Online and Social Media Presence

Embed Graph
Report incorrect company information

Chembio News and Updates

Zika Virus Testing Market reach 120 million US$ by the end of 2025

The global Zika Virus Testing market is valued at 96 million US$ in 2017 and will reach 120 million US$ by the end of 2025, growing at a CAGR of 3.1% during 2018-2025. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information

Chembio Company Life and Culture

Report incorrect company information